Project Details
Description
Alternative splicing plays a crucial role in the life cycle of the
DNA tumor virus SV40, as well as other viruses, and in the
expression of numerous cellular genes. For example, the SV40
early transcript can be spliced to produce the mRNAs encoding
both the large tumor antigen, which is required for both viral
replication and oncogenic cell transformation, and the small
tumor antigen, whose function is also related to cell growth.
Despite significant advances in our understanding of the general
mechanism of pre mRNA splicing, little is known about the
factors that control alternative splicing. This question is of
particular significance because of the increasing evidence that
regulated splicing plays an important role not only in the
replication of oncogenic viruses, but also in the control of genes
that are expressed at different developmental stages or in
different tissues. The experiments proposed here are designed to
provide insights into the factors that control alternative splicing,
how they function and how they themselves are controlled. The
following specific issues will be addressed: Using in vitro
mutagenesis techniques, sequences crucial for controlled
alternative splicing of SV40 pre mRNAs will be identified both by
transfection of different types of cultured mammalian cells, and
by micro-injection of X. laevis oocytes. The pathways and
parameters of SV40 early splicing will be investigated by using
extracts of mammalian cells to process pre mRNAs in vitro. Also
using in vitro processing systems, the identities of trans-acting
factors that influence the choice of alternative splicing pathways
will be determined. Possible changes in the nature of trans-acting
factors during development will be investigated by introducing
SV40 RNA (or DNA) into X. laevis oocytes, ova and embryos.
Finally, regulation of genes that encode splicing factors, the
human U1 and U2 genes, will be studied, and the possibility that
SV40 T antigen, or a cellular homologue, can affect expression of
these genes will be investigated.
Status | Finished |
---|---|
Effective start/end date | 7/6/87 → 6/30/92 |
Funding
- National Cancer Institute
ASJC Scopus Subject Areas
- Virology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.